Bleeding News and Research

RSS
Physicians and health professionals need to be on alert for caregiver-fabricated illness in children

Physicians and health professionals need to be on alert for caregiver-fabricated illness in children

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Health professionals need to be alert for fabricated illness in child, says researcher

Health professionals need to be alert for fabricated illness in child, says researcher

Scientists grow cells that line blood vessels from human iPSCs

Scientists grow cells that line blood vessels from human iPSCs

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Takeda announces publication of data from two vedolizumab Phase 3 studies for ulcerative colitis and Crohn’s disease

Drug oxytocin may contribute to postpartum bleeding, researchers find

Drug oxytocin may contribute to postpartum bleeding, researchers find

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

New antibody drug shows positive results for treating Crohn's disease, ulcerative colitis

Researchers report overall increase in use of tPA to dissolve clots blocking arteries

Researchers report overall increase in use of tPA to dissolve clots blocking arteries

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

FDA grants Orphan Drug Designation to Alnylam ALN-AT3 for treatment of hemophilia B

Older heart patients present unique challenges for determining optimal dosages of medications

Older heart patients present unique challenges for determining optimal dosages of medications

"Risk calculator" enables doctors to estimate risk of venous thrombosis

"Risk calculator" enables doctors to estimate risk of venous thrombosis

Computer model to improve design of artificial platelets and treat blood disorders

Computer model to improve design of artificial platelets and treat blood disorders

Dermatologists provide tips to help psoriasis patients

Dermatologists provide tips to help psoriasis patients

One-third of patients with heart pumps develop infection at abdominal power connection site

One-third of patients with heart pumps develop infection at abdominal power connection site

Study: Mental health services should be included into disaster response plans

Study: Mental health services should be included into disaster response plans

Strathclyde team develops new type of Raman laser that harnesses diamonds to produce light beams

Strathclyde team develops new type of Raman laser that harnesses diamonds to produce light beams

Prothrombin complex concentrates more effective at reversing hemorrhage caused by warfarin

Prothrombin complex concentrates more effective at reversing hemorrhage caused by warfarin

Clot-inhibiting drug apixaban shows added benefits in adults with non-valvular atrial fibrillation

Clot-inhibiting drug apixaban shows added benefits in adults with non-valvular atrial fibrillation

Interactive 3-D simulation platform offers surgical residents to hone patient management skills

Interactive 3-D simulation platform offers surgical residents to hone patient management skills

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.